Locations
Redwood City, CA, USA · San Francisco, CA, USA · South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2018
Earli is a biotechnology company focused on revolutionizing cancer detection and treatment through its innovative Synthetic Biopsy technology. Founded by Dr. Sam Gambhir and Cyriac Roeding, the company aims to turn cancer against itself by designing programmable genetic constructs that activate only in cancer cells, prompting them to produce synthetic biomarkers that make the cancer visible for early detection. This approach not only enhances the accuracy of cancer diagnosis but also allows for timely intervention, significantly improving patient outcomes. With a mission to make cancer a benign experience, Earli is positioned at the forefront of early cancer detection, leveraging cutting-edge science and technology to address one of the most pressing challenges in oncology.
Something looks off?On-site & Remote